Tucuvi continues its internationalization. Spanish company specializing in digital healthwhich operates with a clinical virtual assistant to monitor and control patients, landed in the United Kingdom, a country where it has introduced its technology to remotely monitor users via telephone calls, according to Marcos Rubio, co-founder of Tucuvi, explained to PlantTwelve.

To deploy its technology in the UK, Tucuvi has started working with Cera, a home healthcare provider, which monitors chronic patients in hospitals in the UK.

Cera’s technology is used by hundreds of care companies who together offer more than one million in-home appointments per week. The goal of this tool is to reduce hospitalization and readmission rates. Similarly, Rubio acknowledged that Tucuvi had started negotiations with the UK health system, the NHS, to expand its services in the country. Among the company’s future goals is to make the jump to the United States, a plan it plans to do next year, according to Rubio.

Tucuvi operates in Portugal through an agreement with CUF Cascais Hospital

The company has a presence in Spain, England and Portugal. In the latter country, its advance occurred earlier in the year, through a deal with CUF Cascais Hospital. Those in charge of the medical center trust the Spanish company to carry out follow-up after discharge from the hospital without overburdening the clinical team.

If the virtual assistant detects any red flags, the clinical team will be notified and they act. The project on Portuguese soil is promoted by innovation, an operational transformation office and a team of nurses at CUF Cascais Hospital.

Tukuvi is health technology Madrid was founded in 2019 which has created virtual assistant Lola to adapt each patient’s follow-up from their home. To date, the company has managed more than one million conversations and its technology frees up to 70% of the nursing team’s time and reduces the average length of stay in hospital by 26%.

The company received 5.5 million euros from the European Commission at the end of 2022

Last summer, Tucuvi closed an 800,000 euro financing round in which some participate business angel and a Portuguese fund linked to the technology sector, whose name was not released.

In addition, at the end of 2022, the company received 5.5 million euros from the European Commission under the EIC Accelerator. Of the total, 2.5 million euros is in the form of non-refundable grants and three million euros investment through the EIC Fund, which will strengthen Tucuvi’s commercial activities.

The resources acquired allowed Tucuvi to start with the development of “project Lola version 2.0”, in addition to providing the tool in more than twenty languages.

The founders of Tucuvi are Marcos Rubio María Gónzalez and Marcos Rubio, two biomedical engineers, which holds the majority of capital. González has an idea for that stub when I worked at Medtronic, an American multinational company specializing in this sector medical technology.